N-terminal pro B-type natriuretic peptide (NT-proBNP) is a marker that indicates cardiac stress related to hemodynamic changes, and it has shown promise in predicting the risk of complications such as heart failure (HF) and pulmonary embolism in COVID-19 patients2,3. The gene discussed is NPPB; the disease is pulmonary embolism.